Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Ponsford

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|December 14, 2020
Testing for antibodies to SARS-CoV-2Dipender Gill, Mark J Ponsford
BMJ (Clinical Research Ed.)|February 6, 2019
Antibody deficiency in patients taking clozapineMark J Ponsford, Stephen Jolles
BMJ (Clinical Research Ed.)|September 5, 2020
Are we underestimating seroprevalence of SARS-CoV-2?Stephen Burgess, Mark J Ponsford, Dipender Gill
Current Opinion in Allergy and Clinical Immunology|October 1, 2019
Clozapine-associated secondary antibody deficiencyMark J Ponsford, Antonio Pecoraro, Stephen Jolles
Current Opinion in Allergy and Clinical Immunology|September 7, 2018
What is new in HIES? Recent insights from the interface of primary immune deficiency and atopyMark J Ponsford, William Rae, Adam Klocperk
Journal of Clinical Immunology|February 12, 2022
COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency CohortMark J Ponsford, Kimberly Evans, Emily M Carne, et al.
Current Opinion in Allergy and Clinical Immunology|September 27, 2022
Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shieldingClare Morgan, Stephen Jolles, Mark J Ponsford, et al.
Future Healthcare Journal|December 23, 2022
Strategies to promote guideline adoption: lessons learned from the implementation of a national COVID-19 hospital guideline across NHS WalesRhys Jefferies, Mark J Ponsford, Chris Davies, et al.
Journal of Clinical Immunology|October 29, 2021
Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case ReportRachel E Bradley, Mark J Ponsford, Martin J Scurr, et al.
Current Opinion in Allergy and Clinical Immunology|October 1, 2021
COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiencyMark J Ponsford, Benjamin M J Shillitoe, Ian R Humphreys, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|December 14, 2020
Testing for antibodies to SARS-CoV-2Dipender Gill, Mark J Ponsford
BMJ (Clinical Research Ed.)|February 6, 2019
Antibody deficiency in patients taking clozapineMark J Ponsford, Stephen Jolles
BMJ (Clinical Research Ed.)|September 5, 2020
Are we underestimating seroprevalence of SARS-CoV-2?Stephen Burgess, Mark J Ponsford, Dipender Gill
Current Opinion in Allergy and Clinical Immunology|October 1, 2019
Clozapine-associated secondary antibody deficiencyMark J Ponsford, Antonio Pecoraro, Stephen Jolles
Current Opinion in Allergy and Clinical Immunology|September 7, 2018
What is new in HIES? Recent insights from the interface of primary immune deficiency and atopyMark J Ponsford, William Rae, Adam Klocperk
Journal of Clinical Immunology|February 12, 2022
COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency CohortMark J Ponsford, Kimberly Evans, Emily M Carne, et al.
Current Opinion in Allergy and Clinical Immunology|September 27, 2022
Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shieldingClare Morgan, Stephen Jolles, Mark J Ponsford, et al.
Future Healthcare Journal|December 23, 2022
Strategies to promote guideline adoption: lessons learned from the implementation of a national COVID-19 hospital guideline across NHS WalesRhys Jefferies, Mark J Ponsford, Chris Davies, et al.
Journal of Clinical Immunology|October 29, 2021
Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case ReportRachel E Bradley, Mark J Ponsford, Martin J Scurr, et al.
Current Opinion in Allergy and Clinical Immunology|October 1, 2021
COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiencyMark J Ponsford, Benjamin M J Shillitoe, Ian R Humphreys, et al.
Pageof 3